Keyphrases
Additional mutations
33%
Amino Acids
33%
Attenuated Virus
33%
Attenuating mutations
33%
Attenuation
100%
Cis-acting RNA Elements
33%
Complementary DNA (cDNA)
33%
Human Respiratory Syncytial Virus (hRSV)
100%
Immunogenicity
33%
Infectious Virus
33%
Intranasal Administration
33%
Live Attenuated
100%
Live Attenuated Vaccine
33%
Mutational Analysis
33%
NS1′
33%
Nucleotide Substitution
33%
Pediatric Pulmonary
33%
Point mutation
33%
Polymerase
33%
Rational Design
100%
Recombinant Form
33%
Recombinant Vaccine
100%
Recombinant Virus
66%
Respiratory Symptoms
33%
Reverse Genetics
100%
Sequence Analysis
33%
Vaccine Candidate
33%
Vaccine Virus
100%
Virus
66%
Pharmacology, Toxicology and Pharmaceutical Science
Amino Acid
100%
Complementary DNA
100%
Human Respiratory Syncytial Virus
100%
Immunogenicity
100%
Live Vaccine
100%
Recombinant Vaccine
100%
Respiratory Tract Disease
100%
Virus Infectivity
100%
Virus Vaccine
100%
Biochemistry, Genetics and Molecular Biology
Amino Acids
50%
Genetic Transcription
50%
Genetics
100%
Human Respiratory Syncytial Virus
100%
Immunogenicity
50%
Point Mutation
50%
Polymerase
50%
Protein Sequencing
50%
RNA
50%
Virus Attenuation
50%
Virus Infectivity
50%
Virus Recombinant
100%
Immunology and Microbiology
Attenuated Vaccine
33%
Genetic Transcription
33%
Human Respiratory Syncytial Virus
100%
Immunogenicity
33%
Live Vaccine
33%
Point Mutation
33%
Recombinant Virus
66%
Respiratory Syncytial Virus
100%
Sequence Analysis
33%
Synthetic Vaccine
100%
Virus Attenuation
33%
Virus Infectivity
33%
Virus Vaccine
100%